Ampicillin

Lore & Background

Ampicillin was the first 'broad spectrum' penicillin, active against both gram-positive and some gram-negative bacteria. It is used to treat infections such as bacterial meningitis, endocarditis, gastrointestinal infections, respiratory infections, and sepsis. It is also given to prevent group B streptococcal infection in newborns and to prevent infections in those with rheumatic heart disease or undergoing certain procedures. Ampicillin can be administered by mouth, injection into a muscle, or intravenously, though the oral form is not used for initial treatment of severe infections.

Origins & Global Significance

What set it apart from earlier penicillins was its status as the first truly broad-spectrum member of that family, capable of targeting both gram-positive and gram-negative organisms. This dual reach made it a cornerstone of antibacterial therapy worldwide.

The World Health Organization recognizes ampicillin on its List of Essential Medicines and goes further by classifying it as critically important for human medicine—a designation that underscores how central the drug remains to global health systems. Because it is available as a generic medication, cost barriers are reduced, allowing access in both high-income and resource-limited settings. More than six decades after its initial identification, ampicillin continues to anchor treatment protocols for a wide array of infections, from routine respiratory ailments to life-threatening conditions like meningitis and sepsis, cementing its place as one of the most enduring antibiotics in clinical practice.

Spectrum of Activity & Clinical Applications

Ampicillin's therapeutic reach spans a remarkable range of bacterial infections. On the gram-positive side, it is effective against Streptococcus pneumoniae, Streptococcus pyogenes, certain Staphylococcus aureus isolates, and notably some Enterococcus species. It stands out as one of the very few antibiotics still active against multidrug-resistant Enterococcus faecalis and E. faecium. Against gram-negative organisms, it covers Neisseria meningitidis, select Haemophilus influenzae strains, and portions of the Enterobacteriaceae family, though most Enterobacteriaceae and Pseudomonas have developed resistance.

Clinically, it treats respiratory infections, urinary tract infections, bacterial meningitis, salmonellosis, otitis media, sinusitis, and sepsis. It is the drug of choice for Listeria monocytogenes in pregnant women and is used prophylactically before dental procedures, vaginal hysterectomies, and C-sections in at-risk patients. Co-administration with sulbactam, a beta-lactamase inhibitor, broadens its effective spectrum, and it is sometimes paired with vancomycin, linezolid, daptomycin, or tigecycline for synergistic effect. However, it is no longer recommended for gonorrhea due to widespread penicillin resistance.

Safety, Allergies & Special Populations

Ampicillin is generally well tolerated and comparatively less toxic than many other antibiotics, with the most frequently reported side effects—diarrhea and skin rash—occurring in roughly ten percent of patients. Less common reactions include nausea, vomiting, itching, and blood dyscrasias, while rare but serious events encompass anaphylaxis, angioedema, Clostridioides difficile colitis, seizures, and serum sickness. The drug is strictly contraindicated in individuals with a known penicillin hypersensitivity, as fatal anaphylactic reactions are possible. It is also not recommended for patients with concurrent mononucleosis, since more than forty percent develop a characteristic skin rash.

In pregnancy, ampicillin is considered safe by both the U.S. FDA (category B) and Australia's TGA (category A), and it crosses the placenta, reaching amniotic fluid concentrations of fifty to one hundred percent of maternal plasma levels. Lactating mothers excrete only minimal amounts into breast milk. In newborns, the drug has a longer half-life and lower plasma protein binding due to immature kidney function. Patients with renal impairment may require dose adjustments.

Routes of Administration & Drug Interactions

Ampicillin can be delivered orally as capsules or suspensions, by intramuscular injection, or through intravenous infusion. The oral formulation is typically reserved as a follow-up step after initial parenteral therapy for severe infections rather than as a first-line treatment. For injectable use, the drug is stored as a dry powder that must be reconstituted before administration.

A critical safety note applies to intravenous delivery: the infusion must be administered slowly, because rapid IV injection has been associated with convulsive seizures. Several important drug interactions warrant clinical attention. Probenecid and methotrexate both reduce the renal excretion of ampicillin, potentially altering its levels in the body.

High doses of ampicillin may elevate bleeding risk when taken alongside warfarin or other oral anticoagulants, possibly through inhibition of platelet aggregation. The drug has also been noted to reduce the effectiveness of oral contraceptives. In pregnant patients, physiological changes increase ampicillin clearance by as much as fifty percent, meaning a higher dose is often necessary to maintain therapeutic blood levels throughout gestation.

Reader's Guide

Ampicillin's significance lies in its role as a foundational broad-spectrum antibiotic, expanding the penicillin family's utility against gram-negative bacteria. It remains on the World Health Organization's List of Essential Medicines, underscoring its continued importance in treating common and serious infections. Its use in pregnancy is considered generally safe, and it is the drug of choice for Listeria monocytogenes in pregnant women.

However, resistance has emerged, notably in gonorrhea and many Enterobacteriaceae, and its spectrum is enhanced by co-administration with sulbactam, a beta-lactamase inhibitor. Ampicillin is available as a generic medication, making it widely accessible. Its legacy includes being a key tool in combating bacterial infections for over six decades, though its effectiveness is increasingly challenged by antibiotic resistance.

Did You Know?

• Over 40% of patients with concurrent mononucleosis develop a skin rash when taking ampicillin.